{"id":"https://openalex.org/W2912916978","doi":"https://doi.org/10.1128/aac.02353-18","title":"Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study","display_name":"Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study","publication_year":2019,"publication_date":"2019-01-23","ids":{"openalex":"https://openalex.org/W2912916978","doi":"https://doi.org/10.1128/aac.02353-18","mag":"2912916978","pmid":"https://pubmed.ncbi.nlm.nih.gov/30670416","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6496160"},"language":"en","primary_location":{"id":"doi:10.1128/aac.02353-18","doi":"https://doi.org/10.1128/aac.02353-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02353-18","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1128/aac.02353-18","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057302419","display_name":"William W. Hope","orcid":"https://orcid.org/0000-0001-6187-878X","observed_orcids":["https://orcid.org/0000-0001-6187-878X"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I2802729160","display_name":"Royal Liverpool and Broadgreen University Hospital NHS Trust","ror":"https://ror.org/009sa0g06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160"]},{"id":"https://openalex.org/I4210125804","display_name":"Broadgreen Hospital","ror":"https://ror.org/03f7qhc68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"William Hope","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-6187-878X","affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017276849","display_name":"Gary Johnstone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gary Johnstone","raw_affiliation_strings":["Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043908553","display_name":"Silvia Cicconi","orcid":"https://orcid.org/0000-0001-5507-6203","observed_orcids":["https://orcid.org/0000-0001-5507-6203"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Silvia Cicconi","raw_affiliation_strings":["Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089192790","display_name":"Tim Felton","orcid":"https://orcid.org/0000-0001-6868-6633","observed_orcids":["https://orcid.org/0000-0001-6868-6633"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210092852","display_name":"Manchester University NHS Foundation Trust","ror":"https://ror.org/00he80998","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852"]},{"id":"https://openalex.org/I4210150798","display_name":"Wythenshawe Hospital","ror":"https://ror.org/05vpsdj37","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210150798"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Timothy Felton","raw_affiliation_strings":["Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester Academic Health Science Centre, Wythenshawe, Manchester, United Kingdom","Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Wythenshawe Hospital, Wythenshawe, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester Academic Health Science Centre, Wythenshawe, Manchester, United Kingdom","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]},{"raw_affiliation_string":"Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Wythenshawe Hospital, Wythenshawe, Manchester, United Kingdom","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I4210092852","https://openalex.org/I4210150798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110214343","display_name":"Joanne Goodwin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joanne Goodwin","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014357831","display_name":"Sarah Whalley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Whalley","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026581722","display_name":"Anahi Santoyo Castelazo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anahi Santoyo-Castelazo","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043427318","display_name":"Virginia Ramos-Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Virginia Ramos-Martin","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006600914","display_name":"Jodi M. Lestner","orcid":"https://orcid.org/0000-0001-6196-5867","observed_orcids":["https://orcid.org/0000-0001-6196-5867"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jodi Lestner","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000323750","display_name":"Leah Credidio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802729160","display_name":"Royal Liverpool and Broadgreen University Hospital NHS Trust","ror":"https://ror.org/009sa0g06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160"]},{"id":"https://openalex.org/I4210125804","display_name":"Broadgreen Hospital","ror":"https://ror.org/03f7qhc68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Leah Credidio","raw_affiliation_strings":["Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030399565","display_name":"Aaron L. Dane","orcid":"https://orcid.org/0000-0002-2997-4074","observed_orcids":["https://orcid.org/0000-0002-2997-4074"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Aaron Dane","raw_affiliation_strings":["Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","DaneStat Consulting, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"DaneStat Consulting, Macclesfield, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102748258","display_name":"Daniel F. Carr","orcid":"https://orcid.org/0000-0001-8028-4282","observed_orcids":["https://orcid.org/0000-0001-8028-4282"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniel F. Carr","raw_affiliation_strings":["MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006847944","display_name":"Munir Pirmohamed","orcid":"https://orcid.org/0000-0002-7534-7266","observed_orcids":["https://orcid.org/0000-0002-7534-7266"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I2802729160","display_name":"Royal Liverpool and Broadgreen University Hospital NHS Trust","ror":"https://ror.org/009sa0g06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160"]},{"id":"https://openalex.org/I4210125804","display_name":"Broadgreen Hospital","ror":"https://ror.org/03f7qhc68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Munir Pirmohamed","raw_affiliation_strings":["MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom","Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066550588","display_name":"Rahim Salim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802729160","display_name":"Royal Liverpool and Broadgreen University Hospital NHS Trust","ror":"https://ror.org/009sa0g06","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160"]},{"id":"https://openalex.org/I4210125804","display_name":"Broadgreen Hospital","ror":"https://ror.org/03f7qhc68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rahim Salim","raw_affiliation_strings":["Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I2802729160","https://openalex.org/I4210125804"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026635936","display_name":"Michael Noel Neely","orcid":"https://orcid.org/0000-0002-1675-8276","observed_orcids":["https://orcid.org/0000-0002-1675-8276"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Neely","raw_affiliation_strings":["Laboratory of Applied Pharmacokinetics, University of Southern California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Applied Pharmacokinetics, University of Southern California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5057302419"],"corresponding_institution_ids":["https://openalex.org/I146655781","https://openalex.org/I2802729160","https://openalex.org/I4210125804"],"apc_list":null,"apc_paid":null,"fwci":3.2559,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.90891161,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"63","issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.022199999541044235,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":1.0},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.746999979019165},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.675000011920929},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.9630115032196045},{"id":"https://openalex.org/C2778335254","wikidata":"https://www.wikidata.org/wiki/Q5137314","display_name":"Cmin","level":4,"score":0.6553560495376587},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.6461338400840759},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6454881429672241},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5407820343971252},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4695981740951538},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45167818665504456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43327343463897705},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.4146222174167633},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.39360329508781433},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3851492702960968},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.37037038803100586},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.10690182447433472},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1128/aac.02353-18","doi":"https://doi.org/10.1128/aac.02353-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02353-18","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5522243","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6496160","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6496160","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6496160","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:30670416","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30670416","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/1592c338-8877-472d-9f93-66fd917b8f60","doi":null,"is_oa":true,"landing_page_url":"https://www.scopus.com/pages/publications/85063661154","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hope, W, Johnstone, G, Cicconi, S, Felton, T, Goodwin, J, Whalley, S, Santoyo-Castelazo, A, Ramos-Martin, V, Lestner, J, Credidio, L, Dane, A, Carr, D F, Pirmohamed, M, Salim, R & Neely, M 2019, 'Software for Dosage Individualization of Voriconazole : a Prospective Clinical Study', Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/AAC.02353-18","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1128/aac.02353-18","doi":"https://doi.org/10.1128/aac.02353-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02353-18","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1435053517","display_name":"Goal-oriented and model-based pharmokinetic dosing of voriconazole in immunocompromised patients","funder_award_id":"CS/08/08/10","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G2100064677","display_name":"Centre for Drug Safety Science (CDSS)","funder_award_id":"MR/L006758/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G2732435371","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0512-10064","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G570999748","display_name":null,"funder_award_id":"CS/08/08","funder_id":"https://openalex.org/F4320334659","funder_display_name":"Research Trainees Coordinating Centre"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320332759","display_name":"Pfizer UK","ror":"https://ror.org/04x4v8p40"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334659","display_name":"Research Trainees Coordinating Centre","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W2017106430","https://openalex.org/W2021298363","https://openalex.org/W2093162201","https://openalex.org/W2101785863","https://openalex.org/W2148605276","https://openalex.org/W2149613723","https://openalex.org/W2153641174","https://openalex.org/W2161744315","https://openalex.org/W2162210327","https://openalex.org/W2162857158","https://openalex.org/W2170305176","https://openalex.org/W2470291098"],"related_works":["https://openalex.org/W2093162201","https://openalex.org/W7212295829","https://openalex.org/W2937233615","https://openalex.org/W4309524972","https://openalex.org/W4408376960","https://openalex.org/W2031785695","https://openalex.org/W3029513024","https://openalex.org/W7130438706","https://openalex.org/W4408376787","https://openalex.org/W4247814324"],"abstract_inverted_index":{"genotype-derived":[0],"metabolizer":[1],"phenotype":[2],"with":[3],"voriconazole":[4,15],"AUC.":[5],"Software":[6],"can":[7],"be":[8],"used":[9],"to":[10,16],"adjust":[11],"the":[12,36,47],"dosages":[13],"of":[14],"achieve":[17],"drug":[18],"exposures":[19],"that":[20],"are":[21],"safe":[22],"and":[23,45],"effective.":[24],"(The":[25],"clinical":[26],"trial":[27],"discussed":[28],"in":[29,35,46],"this":[30],"paper":[31],"has":[32],"been":[33],"registered":[34],"European":[37],"Clinical":[38],"Trials":[39],"Database":[40],"under":[41,50],"EudraCT":[42],"no.":[43,51],"2013-0025878-34":[44],"ISRCTN":[48],"registry":[49],"ISRCTN83902726.).":[52]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2019-02-21T00:00:00"}